We’re bringing back a Twist classic! Whether you wear them solo or pair them with sandals (we won’t tell anyone 🤫), a fresh pair of Twist socks is the ultimate lab accessory. Learn how to claim your pair here: www.twistbioscience.com/promo/summer... *Terms and conditions apply @twistbioscience.com

What if a negative test isn't the end of the story? When PCR couldn't identify the virus behind a deadly hemorrhagic fever outbreak, Twist's Comprehensive Viral Panel and whole genome sequencing helped identify the rare Bundibugyo Ebola strain: biopharmaboardroom.com/expert-opini...

MRD Express: Rapid, scalable, and high-performance custom target enrichment for minimal residual disease monitoring: aacrjournals.org/cancerres/ar...

👀 MRD & cancer researchers: This substack from James Hadfield focuses on “exploring the enabling technologies that could fundamentally democratize MRD testing, moving it out of large centralised labs & into community oncology centres near patients.”

Did you see Josh Kerr destroy the men’s mile world record? 3 minutes and 42.66 seconds… He’s fast, and you know what else is fast? Twist Express Genes! 🏃‍♂️ Clonal Genes made in the US to your specifications and shipped to you in as few as 4 days.* www.twistbioscience.com/products/gen...

Anyone following the World Cup? 🏆 If so, respond with an emoji of which team you're rooting for! ⚽ Since Twist is a data-driven company, we conducted an informal poll. Twisters from around the world weighed in about who they are cheering on, and the results are in…

That’s a wrap on the Twist Oncology Roadshow in Singapore & India! Experts in the field gathered to discuss everything from MRD & solid tumors to comprehensive genomic profiling & liquid biopsy. Special thanks to all the panelists, organizers, & attendees! @twistbioscience.com

Fast + efficient + novel antibody development? New from the Institute for Protein Innovation & @harvardmed.bsky.social, led by principal scientist Deepash Kothiwal, reports a novel framework for making synthetic recombinant antibodies that can generate data specifically optimized for ML integration.

Our CEO and co-founder Emily Leproust, and Christine Wormuth, former U.S. secretary of the army, president and CEO of @nti.org discuss supporting scientific innovation while reducing deliberate misuse of AI. Read why it is important here: www.newsweek.com/us-china-mus...

Superior uniformity, deeper insights. The Twist Bioscience NGS advantage Watch our talk led by Maria Harbo at the recent congress of ESHG held in beautiful Gothenburg 🇸🇪 here: m.youtube.com/watch?v=VpF3... @twistbioscience.com

🤖 AI: Here's 10K new DNA designs 🧑‍🔬 Researchers: Great, who can actually make them? At Twist, we're making even the toughest DNA sequences routine so science doesn't have to wait for the impossible. Emily Leproust explains how: www.the-scientist.com/the-power-of...

🧬 Decode the Virome with Unmatched Precision Stop searching for the "needle in the haystack" & start seeing the whole field Tracking an emerging outbreak or profiling complex viral communities? Our Broad Viral NGS Panel provides the resolution to move from detection to discovery

Traditional surveillance can miss the silent spread of viruses, but new approaches are changing the game. Jelle Matthijnssens shares groundbreaking research comparing emergency department indoor air and citywide wastewater monitoring for respiratory and enteric viruses…

Vibe check, we’re about half way through the year, which one a we feeling describes the first part of 2026?

Summer brings time for learning at your leisure, browse our free webinar library! ☀️ Learn about topics including: AI, base editors, antibody discovery, liquid biopsy, cancer research, infectious disease, drug development, synthetic DNA, & MUCH more: www.twistbioscience.com/resources/we...

“John Dye: The 2026 Ebola Outbreak Got a Four-Month Head Start Because No One Ran the Right Test” Hear John Dye of USAMRIID discuss the state of the Bundibugyo Ebola virus outbreak including testing, treatments, and more with Vincent Racaniello on a special edition of the TWiV

We are missing #ESHG2026 already! The recording of our corporate session with Maria Harbo, Claes Ladenvall, & Isabell Schumann will be available soon. Thanks to everyone who visited with us and sharing your work. We loved hearing about it and also sharing our latest. @twistbioscience.com

Challenging samples shouldn't mean compromised results. The Twist RNA Exome is designed to detect more gene targets with fewer reads, even from FFPE and low-input tumor samples. Learn more: www.twistbioscience.com/contact @twistbioscience.com

Today, on this Juneteenth, we are honoring Black history At Twist, this goes far beyond a single day of recognition. It is about how we show up for each other, respect, valuing differences, & recognizing the individual That commitment is part of who we are & woven into our DNA

iGEM teams! We have free DNA for you! We are offering every team complimentary synthesis of 20kb of DNA, available as either Gene Fragments or Express Clonal Genes. Your synthetic DNA arrives ready to use, cloned into a Twist stock vector or an iGEM vector: competition.igem.org/sponsorships...

We’ve got the latest on MRD (Minimal Residual Disease). In a recent roundtable convened by The Scientist experts came together to discuss the state of MRD. Read “As the Science of MRD Settles, Operational Challenges Mount” here: www.twistbioscience.com/blog/science... @twistbioscience.com

How can you achieve faster, more sensitive viral detection without increasing workflow complexity? 📺 Watch the webinar on demand: “Rapid, Sensitive Pathogen Detection using Hybridization Capture and Nanopore Sequencing” www.twistbioscience.com/resources/we... @twistbioscience.com

Twist is on the front lines of genomic sequencing for recent outbreak response activities & we couldn’t be more thrilled to see our Comprehensive Viral Research Panel utilized in the preliminary analysis of Orthohantavirus andesense virus: virological.org/t/preliminar... @twistbioscience.com

We’re proud to support sequencing Bundibugyo Ebola samples. Using our Twist Comprehensive Viral Research Panel, two near-complete genomes were generated from serum and oropharyngeal swab samples (Ct 17.27 and 25.78) in under 16 hours from receipt: www.genomeweb.com/infectious-d...

What’s the toughest sample type in your NGS Library Prep workflow? Let us know in the comments. A) cfDNA (liquid biopsy) B) FFPE (degraded tumor tissue) C) Low input gDNA D) Other (comment below!)

In Support of Mandatory Nucleic Acid Synthesis Screening… As AI rapidly lowers the barriers to advanced biological capabilities, mandatory screening of synthetic DNA orders is an urgent, proven safeguard against misuse: screendna.org @twistbioscience.com

RNA seq budget limited? With Twist: 🧬 Maximize data/run with exceptional capture uniformity ⬇️ sequencing volume & get more usable data ⚡30% Higher Efficiency: Enrich transcripts for greater sensitivity at lower read depths vs. whole transcriptome seq methods: www.twistbioscience.com/resources/te...

We're excited to join innovative minds at #ESHG2026 and meet with you again, this time in Gothenburg! 👋 Booth 508 🥗 Lunch session: Monday, 15 June 2026 📊 Posters, 🎤 speakers and more: www.twistbioscience.com/events/eshg-...

See you in one week, #FOGBoston! 🎤 Hear from Ryan Hegarty, Regional Commercial Development Manager, as he presents “Twist Library Preparation Kits developed with Novel Enzyme Engineering.” • Jun 3, 2026 at 1:35 PM to 1:50 PM • Innovation Stage @flgenomics.bsky.social

The @alexbick.bsky.social lab at VUMC genetics, just opened the door to more possibilities in liquid biopsy: plasma cfDNA instead of whole blood in CHIP: ashpublications.org/bloodadvances/… Thank you to the authors for choosing Twist a Methyome Panel + EM-seq kits to support this work! 🧬